Venetoclax With Obinutuzumab and Magrolimab (VENOM) in Relapsed and Refractory Indolent B-cell Malignancies
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
University of Nebraska
M.D. Anderson Cancer Center
University of California, Davis
M.D. Anderson Cancer Center
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
Children's Oncology Group
Fred Hutchinson Cancer Center
Children's Oncology Group
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center